<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND OBJECTIVES: This study examined predictors of the annual decline in estimated GFR (eGFR) in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and preserved kidney function </plain></SENT>
<SENT sid="1" pm="."><plain>DESIGN, SETTING, PARTICIPANTS, &amp; MEASUREMENTS: In a prospective, observational cohort study, 1682 individuals with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and baseline eGFR ≥60 ml/min per 1.73 m(2) (as estimated by the <z:hpo ids='HP_0011010'>Chronic</z:hpo> <z:e sem="disease" ids="C0022658" disease_type="Disease or Syndrome" abbrv="">Kidney Disease</z:e> Epidemiology Collaboration equation) were followed for 10 years </plain></SENT>
<SENT sid="2" pm="."><plain>Linear regression was used to estimate participants' changes in eGFR over time </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: During follow-up, 263 (15.6%) individuals had a rapid eGFR decline defined as &gt;4.0% per year </plain></SENT>
<SENT sid="4" pm="."><plain>Average eGFR decline was -5.8 ± 3 and -0.6 ± 2 ml/min per 1.73 m(2) per year in rapid decliners and nondecliners, respectively </plain></SENT>
<SENT sid="5" pm="."><plain>Compared with normotensive, normoalbuminuric patients (-0.2 ± 0.2 ml/min per 1.73 m(2) per year), those with <z:hpo ids='HP_0000822'>hypertension</z:hpo> (-1.0 ± 0.1 ml/min per 1.73 m(2) per year), <z:chebi fb="0" ids="35143">hemoglobin</z:chebi> A(1c)≥7% (-1.0 ± 0.1 ml/min per 1.73 m(2) per year), longer <z:mp ids='MP_0002055'>diabetes</z:mp> duration (-1.0 ± 0.1 ml/min per 1.73 m(2) per year), <z:hpo ids='HP_0001513'>obesity</z:hpo> (-1.2 ± 0.1 ml/min per 1.73 m(2) per year), insulin treatment (-1.5 ± 0.1 ml/min per 1.73 m(2) per year), <z:mp ids='MP_0002959'>microalbuminuria</z:mp> (-1.3 ± 0.2 ml/min per 1.73 m(2) per year), or macroalbuminuria (-2.7 ± 0.4 ml/min per 1.73 m(2) per year) had significantly faster age-adjusted annual eGFR declines </plain></SENT>
<SENT sid="6" pm="."><plain>Multivariable linear regression analyses revealed that <z:mp ids='MP_0002871'>albuminuria</z:mp> (P&lt;0.001) was the strongest predictor of annual eGFR decline </plain></SENT>
<SENT sid="7" pm="."><plain>Other independent predictors of annual eGFR decline were older age, <z:hpo ids='HP_0000822'>hypertension</z:hpo>, insulin treatment, and lower baseline eGFR </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: Annual eGFR decline is predicted by multiple modifiable risk factors in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and preserved kidney function </plain></SENT>
</text></document>